Biotoxtech Co., Ltd. (KOSDAQ:086040)
1,999.00
-31.00 (-1.53%)
At close: Oct 30, 2026
Biotoxtech Revenue
Biotoxtech had revenue of 14.46B KRW in the quarter ending June 30, 2026, with 50.29% growth. This brings the company's total for the last twelve months to 52.48B, up 20.88% year-over-year. In the year 2025, Biotoxtech had annual revenue of 47.02B with 13.73% growth. That makes Biotoxtech the 29,599th largest company in the world by revenue and 1,831st in South Korea.
Revenue (ttm)
52.48B
Revenue Growth
+20.88%
P/S Ratio
0.60
Revenue / Employee
279.13M
Employees
188
Market Cap
31.43B
Revenue by Geography
- South Korea 39.11B 83.2%
- Overseas 7.91B 16.8%
Fiscal year ended Dec 31, 2025 See the full Biotoxtech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.02B | 5.68B | 13.73% |
| Dec 31, 2024 | 41.34B | 8.71B | 26.69% |
| Dec 31, 2023 | 32.63B | -4.66B | -12.50% |
| Dec 31, 2022 | 37.29B | 4.57B | 13.98% |
| Dec 31, 2021 | 32.72B | 6.29B | 23.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dyc Co.,Ltd. | 128.91B |
| Maniker F&G | 111.67B |
| YounglimwonSoftLab Co.Ltd | 85.58B |
| Seoulin Bioscience | 83.17B |
| NHN BUGS | 67.03B |
| Macromill Embrain | 58.89B |
| BBC Co., Ltd. | 55.13B |
| Wise birds | 50.47B |